Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 638-645

  De Vries, Helga E ^a   Buchner, Bas ^a   Van Berkel, Theo J C ^a   Kuiper, Johan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Macrophage derived foam cells; Monocytes; Oxidized lipoproteins; Scavenger receptor

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; FEMALE; FOAM CELL; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPID DIET; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033049512     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.638     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 1986;314:488-500.
2. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987;84:2995-2998.
3. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 1990;343:570-572.
4. Freeman M, Ashkenas J, Rees DJG, Kingsley DM, Copeland NG, Jenkins NA, Krieger M. An ancient highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci U S A. 1990;87: 8810-8814.
5. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J Supramol Struct. 1980;13:67-81.
6. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87:9133-9137.
7. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature. 1990;343:1313-1319.
8. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36 related class B scavenger receptor. J Biol Chem. 1994; 269:21003-21009.
9. Huang YH, Rönnelid J, Frostegård J. OxLDL induces enhanced antibody formation and MHC Class II-dependent IFN-γ production in lymphocytes from healthy individuals. Arterioscler Thromb Vasc Biol. 1995;15: 1577-1583.
10. Endemann G, Stanton LW, Madden KS, Bryant M, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
11. Alessio M, De Monte L, Scirea A, Gruarin P, Tandon NN, Sitia R. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation. J Biol Chem. 1996;271:1770-1775.
12. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97 kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidyl-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A. 1996;92:9580-9584.
13. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1997;93:14833-14838.
14. Ottnad E, Parthasarathy S, Sambrano G, Ramprasad MP, Quehenberger O, Kondratenko N, Green S, Steinberg D. A macrophage receptor for OxLDL distinct from the receptor for AcLDL: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A. 1995;92:1391-1395.
15. 2 mimics cell-mediated oxidative modification. J Lipid Res. 1988;29:745-753.
16. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of LDL that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
17. Parthasarathy S, Steinberg D, Witztum JL. The role of OxLDLs in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219-225.
18. Palinski W, Rosenfeld ME, Ylä-Herttuala S. LDL undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
19. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest. 1991;87:90-99.
20. Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem. 1975;65:42-49.
21. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized LDL and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1976;73: 3178-3182.
22. McFarlane AS. Efficient trace-labelling of proteins with iodine. Nature. 1958;182:53-58.
23. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins, I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972;260:212-221.
24. Van Berkel TJC, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and AcLDL in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem. 1991;266:2282-2289.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-160.
26. Bickel PE, Freeman MW Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor mRNA that is absent from endothelial cells. J. Clin. Invest. 1992;90:1450-1457.
27. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell. 1989; 58:95-101.
28. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993;81: 1607-1613.
29. Holness CL, Da Silva RP, Fawcett J, Gordon S, Simmons DL. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/Igp family. J Biol Chem. 1993;268:9661-9663.
30. Libby P, Clinton SK. The role of macrophages in atherogenesis. Curr Opin Lipidol. 1993;4:355-363.
31. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt K, Van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386:292-296.
32. Geng YJ, Holm J, Nygren S, Bruzelius M, Stemme S, Hansson GK. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon gamma. Arterioscler Thromb Vasc Biol. 1995;15:1995-2002.
33. Hiltunen TP, Jukka JS, Nikkari T, Ylä-Herttula. Expression of LDL receptor, VLDL receptor, LDL-receptor related protein, and scavenger receptor in rabbit atherosclerotic lesions. Circulation. 1998;97: 1079-1086.
34. Van Velzen AG, Da Silva RP, Gordon S, Van Berkel TJC. Characterization of a receptor for oxidized low density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem J. 1997;322:411-415.
35. De Rijke YB, Van Berkel TJC. Liver endothelial cells and Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoprotein. J Biol Chem. 1994;269:1-4.
36. Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Arterioscler Thromb Vasc Biol. 1995;15:269-275.
37. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 1997;272:21654-21659.
38. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 1995;96: 1859-1865.
39. Van der Kooij M, Morand OH, Kempen HJ, Van Berkel TJC. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with GM-CSF. Arterioscler Thromb Vasc Biol. 1996;16: 106-114.
40. Geng Y, Hansson GK. IFN-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest. 1992;1992:89:1322-1330.
41. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte-macrophage differentiation; potential role of CD36 in foam cell formation. Blood. 1996;87: 2020-2028.
42. Li HM, Freeman M, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest. 1995;95:122-133.
43. Lei X, Buja M. Detection and localization of tumor necrosis factor-α in WHHL rabbit arteries. Atherosclerosis. 1996;125:81-89.
44. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol. 1996;16:1019-1025.